Menu
Back to User profile » Dr Jordi Martinez-Serra
Papers published by Dr Jordi Martinez-Serra:
Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma
Garcia-Recio M, Martinez-Serra J, Mestre F, Bento L, Gines J, Ramos R, Daumal J, López P, Sampol A, Gutierrez A
OncoTargets and Therapy 2018, 11:6599-6603
Published Date: 8 October 2018
Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report
Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A
OncoTargets and Therapy 2016, 9:5507-5511
Published Date: 7 September 2016
Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma
Gutierrez A, Rodriguez J, Martinez-Serra J, Gines J, Paredes P, Garcia F, Vercher J, Balanzat J, del Campo R, Galan P, Morey M, Sampol A, Novo A, Bento L, García L, Bargay J, Besalduch J
OncoTargets and Therapy 2014, 7:2093-2100
Published Date: 13 November 2014
Fluorescence resonance energy transfer-based real-time polymerase chain reaction method without DNA extraction for the genotyping of F5, F2, F12, MTHFR, and HFE
Martinez-Serra J, Robles J, Nicolàs A, Gutierrez A, Ros T, Amat JC, Alemany R, Vögler O, Abelló A, Noguera A, Besalduch J
Journal of Blood Medicine 2014, 5:99-106
Published Date: 25 June 2014
xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies
Martinez-Serra J, Gutierrez A, Muñoz-Capó S, Navarro-Palou M, Ros T, Amat JC, Lopez B, Marcus TF, Fueyo L, Suquia AG, Gines J, Rubio F, Ramos R, Besalduch J
OncoTargets and Therapy 2014, 7:985-994
Published Date: 12 June 2014